Consolidated Statements of Stockholders' Equity (Deficit) - USD ($)	Common Stock	Additional Paid-in Capital	Accumulated Deficit	Total
Balance, beginning at Sep. 30, 2023	$ 130,128	$ 453,350,281	$ (467,918,186)	$ (14,437,777)
Balance, beginning (in shares) at Sep. 30, 2023	13,012,833
Increase (Decrease) in Stockholders' Equity
Stock-based compensation expense		1,272,611		1,272,611
Net Income (Loss)	$ 0	0	(11,178,239)	(11,178,239)
Balance, ending at Dec. 31, 2023	$ 130,128	454,622,892	(479,096,425)	(24,343,405)
Balance, ending (in shares) at Dec. 31, 2023	13,012,833
Balance, beginning at Sep. 30, 2024	$ 239,057	469,969,333	(543,284,900)	(73,076,510)
Balance, beginning (in shares) at Sep. 30, 2024	23,905,635
Increase (Decrease) in Stockholders' Equity
Sale of common stock, net of issuance costs	$ 10,000	1,726,042		1,736,042
Sale of common stock, net of issuance costs (in shares)	1,000,000
Stock-based compensation expense		3,672,420		3,672,420
Net Income (Loss)			17,377,614	17,377,614
Balance, ending at Dec. 31, 2024	$ 249,057	$ 475,367,795	$ (525,907,286)	$ (50,290,434)
Balance, ending (in shares) at Dec. 31, 2024	24,905,635